Bone marrow (BM) chimeras prepared by complete recipient ablation (A-+B) exhibit donor-specific tolerance, yet survival is often limited by graft-versus-host disease (GVHD). Negative selection of potentially donor-reactive T cells, as assessed by relative T-cell receptor (TCRI-V, expression, is dependent on donor BM-derived deleting ligands. Mixed chimerism and tolerance for both donor and host antigens can be achieved using partial recipient myeloablation with 500 cGy total-body irradiation (TB11 before transplantation followed by cyclophosphamide (CyP) on day +2. To examine the influence of residual host elements on negative selection, the peripheral TCR-V, repertoire was analyzed in partially ablated C57BLIlOSnJ (B101 recipients reconstituted with BM from major histocompatibility complex (MHCI-disparate BlO.BR/SgSnJ or MHC, Hh-l and Mls-disparate LONAL DELETION, or negative selection, of autoreactive T cells was postulated more than 35 years ago by Burnet.' It is now considered to be the primary mechanism responsible for the acquisition of immunologic selftolerance and the development of the T-cell repertoire. Monoclonal antibodies (MoAbs) specific for the variable region of the p chain of the T-cell receptor (TCR-V,), and transgene studies, have shown that negative selection of T lymphocytes primarily occurs within the Interaction of the TCR with specific endogenous retroviral integrant products, known as minor lymphocyte-stimulating (Mls) antigens, expressed on bone mmow (BM)-derived cells, results in the deletion of potentially autoreactive T cells during the double-positive TCRI"" CD4+CD8+ stage of T-cell development by programmed cell death, or apoptosis.6"2 Expression of the various Mls antigens in association with self-major histocompatibility complex (MHC) antigens, especially I-E, shape the T-cell repertoire through the deletion of potentially autoreactive V,+ T-cell populations.6 Although negative selection occurs most efficiently in developing T lymphocytes, mature activated T cells have also been shown to be deleted by apoptosis.13,14
LONAL DELETION, or negative selection, of autoreactive T cells was postulated more than 35 years ago by Burnet.' It is now considered to be the primary mechanism responsible for the acquisition of immunologic selftolerance and the development of the T-cell repertoire. Monoclonal antibodies (MoAbs) specific for the variable region of the p chain of the T-cell receptor (TCR-V,), and transgene studies, have shown that negative selection of T lymphocytes primarily occurs within the Interaction of the TCR with specific endogenous retroviral integrant products, known as minor lymphocyte-stimulating (Mls) antigens, expressed on bone mmow (BM)-derived cells, results in the deletion of potentially autoreactive T cells during the double-positive TCRI"" CD4+CD8+ stage of T-cell development by programmed cell death, or apoptosis.6"2 Expression of the various Mls antigens in association with self-major histocompatibility complex (MHC) antigens, especially I-E, shape the T-cell repertoire through the deletion of potentially autoreactive V,+ T-cell populations. 6 Although negative selection occurs most efficiently in developing T lymphocytes, mature activated T cells have also been shown to be deleted by apoptosis. 13, 14 Roberts et a1 showed that deletion of potentially donorreactive T cells is a major mechanism for achieving and maintaining tolerance in BM chimeras conditioned with lethal irradiati~n.'~ However, it is clearly not the sole mechanism, because deletion occurred only if the donor marrow was from a deleting strain. SJL, as well as B10, mice are permissive for expression of Vp6+ and V,17a+ T cells, whereas CBNJ (Mls"; IEk) mice delete these ~ubfarnilies.~~.~' Transplantation of a mixture of SJL and B6 X CBNJ BM into B10 recipients resulted in the deletion of V,6+ and V,17a+ T cells.I5 However, V,6+ and Vp17a+ T-cell subfamilies were not deleted when the Mls" and IEk determinants were expressed only by the host thymic stroma in SJL-*B6 X CBNJ chimeras. Nonetheless, tolerance for these determinants was present in vitro due to the induction of clonal anergy, as characterized by the survival of potentially selfreactive T cells and the lack of proliferation and interleukin-2 (IL-2) production in vitro in response to self-antigen^.^.'*-^^ BALBlcByJ donors, which delete V,5+ and 11+ or V,3+, 5+, and 11+ TCR subsets, respectively. As in myeloblated recipients, donor-reactive subfamilies were deleted in BlO.BR-+BlO and BALBirB10 chimeras, suggesting that donor l-E and minor lymphocyte-stimulating (MIS) antigens contribute to the deleting ligands in the nonmyeloablated host. In striking contrast to completely ablated BlO+BlO.BR chimeras, partially ablated recipients showed intramedullary l-E expression in the thymus and deleted host-reactive V,5+ and V,ll+ subfamilies. These data demonstrate that efficient clonal deletion occurs after partial myeloablation and that both donor and host ligands contribute to TCR repertoire selection. 0 1996 by The American Society of Hematology.
These findings established that in fully ablated BM chimeras, clonal deletion is dependent on the expression of deleting ligands on donor-derived BM cell^.^,'^ In contrast, when Mls" and IEk determinants were present only on radioresistant host elements, anergy and not deletion of autoreactive V,-TCR subsets occurred. Unlike clonal deletion, anergy is reversible with the restoration of T-cell responsiveness, in the presence of IL-2.18. 21.22 Although BM chimeras reconstituted with donor BM after complete recipient ablation (A-B) exhibit donor-specific transplantation tolerance for subsequent tissue and organ grafts, survival is limited by graft-versus-host disease (GVHD) and an increased susceptibility to i n f e~t i o n .~~.~~ In contrast, mixed allogeneic chimerism resulting from reconstitution with a mixture of syngeneic and allogeneic (A + B-A) BM confers tolerance to both donor and host alloantigens with a relative resistance to GVHD.27 The mechanism of tolerance induction by BM is still being characterized, but may be influenced by a number of variables, including the type of host conditioning used. It has now been established that mixed chimerism can be achieved across MHC disparities with incomplete recipient myeloablation.z8-3' Although one could hypothesize that the fundamental mechanisms of tolerance induction are likely to be the same after complete and incomplete host ablation, the kinetics of tolerance induction, the T-cell repertoire selected, and the dominant mechanism for maintaining long-term tolerance may be significantly different when the recipient is not totally ablated before transplantation.
Cyclophosphamide (CyP)-induced tolerance to limited antigenic disparities has been achieved through the generation of suppressor and/or anergic mechanisms with or without the requirement for donor chim e r i~m .~' .~~ With more disparate donor and recipient combinations, a requirement for significant levels of donor chimerism and at least transient clonal deletion, has been o b~e r v e d .~' .~~ These differences suggest that the mechanisms for the induction and maintenance of tolerance are distinct, and are influenced by the degree of genetic disparity between the donor and host, as well as the strategy for host myeloablation.
We have recently established that mixed chimerism can be achieved without complete recipient ablation across multiple MHC, minor, and Hh-l antigen disparities using a radiationbased conditioning approach (B1O.BR-B 10; B 1 W B 10.BR; BALB/c-+B Recipients conditioned with 500 cGy totalbody irradiation (TBI) and a single dose of intraperitoneal CyP on day +2, engraft and exhibit permanent donor-specific transplantation tolerance in vitro and in vivo for skin and primarily vascularized cardiac allografts. This approach is not completely ablative, because animals that are conditioned but not transplanted repopulate as syngeneic. B10 .BR mice delete several V, subfamilies, including V$' and V,1 l + peripheral T cells,22,36"8 whereas B10 mice T
In the current study, we have analyzed V, expression in BM chimeras after partial and complete recipient conditioning to determine the importance of MIS antigen expression by recipient and donor elements on the induction and maintenance of tolerance. All partially ablated B10 recipients engrafted as mixed chimeras (61.9% ? 7.3% donor), irrespective of the donor BM strain, and showed a selective deletion of donor-reactive V$ T-cell subsets. Similarly, B1O.BR recipients transplanted with B10 donor BM deleted potentially host-reactive subsets, whereas completely ablated recipients (950 cGy TBI) did not. Deletion of V,-TCR subsets directly correlated with the presence of mixed chimerism and I-E' cells within the thymic medulla of the host. These data suggest that deletional tolerance across multiple histocompatibility barriers in partially ablated recipients, as achieved in this model of mixed chimerism, is bidirectional, with both donor and recipient BM-derived ligands contributing to development of the T-cell repertoire. 
MATERIALS AND METHODS

Animals.
Male, 6-to 8-week-old C57BL/lOSnJ (B10; H-2b), B1O .BWSgSn.l (B1O.BR; H-2k), and BALB/cByJ (BALBk; H-2d) mice were purchased from the Jackson Laboratory, Bar Harbor, ME. Animals were housed in a specific pathogen-free facility at the Biomedical Science Tower.
Preparation of chimeras. B10 male recipients were irradiated with 950 cGy (complete ablation) or 500 cGy (partial ablation) TB1 from a '"CS source (Nordion, Ontario, Canada). Using sterile technique, BM was prepared from the femurs and tibias of donor BIO.BR Statistical analysis. To determine if the deletion of TCR-V0 subsets was statistically significant, the relative V, expression for each experimental group was compared with the expression seen in the nondeleting B10 strain using the unpaired Student's t test. Analysis of variance (ANOVA) was used for statistical comparison of relative V, expression among the groups containing different levels of chimerism.
Immunohistochemical staining. Tissues for histologic analysis were immediately snap-frozen in pentane and kept at -70°C until use. Frozen sections (4 pm) of thymus were fixed in cold acetone, air-dried, and blocked for endogenous peroxidase and nonspecific protein interactions before incubation with 50 pL of biotinylated antimouse class I1 MoAb (I-Ek, clone 17-3-3, mouse IgG?,; Pharmingen) for I hour at room temperature. This primary antibody was followed by incubation with the avidin-biotin complex conjugate (Vector Labs, Burlingame, CA) and aminoethylcarbizol (AEC; Biomeda, Foster City, CA). Slides were counterstained with hematoxylin. Specimens were overlaid with CrystaYmount (Biomed) and, after hardening, were coverslipped using Accu-mount (Baxter Scientific Products, McGaw Park, IL). and Vs14' subsets were not deleted. Deletion of V,S' and Vol 1 ' subfamilies was also analyzed with respect to the level of donor chimerism present in partially ablated chimeras ( I 1.9% to 70% chimerism). The extent of V$ and V,I 1 deletion was not influenced by the degree of donor chimerism ( Table l ) .
RESULTS
Donor-derived ligands contribute to V, deletion
Pattern of TCR-V, deletion across MHC, Hh-l, and MIS diferences in a partinll~ ablated host. The TCR-V, repertoire was also enumerated in the BALB/c+B I O strain combination to establish whether deletion of donor-reactive T-cell subsets occurred in the presence of MHC, MIS. and other minor antigen disparities. The BALB/c mouse, which is MHC-, Hh-I-, and Mls-disparate (H-2"; I-E"; MW) from BIO, and deletes V,3', V$-, and V,1 1' T cells, was used as a donor for partially ablated BIO recipients. Chimerism was present in all animals at the time of V, analysis (89.7% ? 1.3%). In all chimeras examined from I to 16 months after BMT (n = 6), specific deletion of V,3' .
V$' , and V,I 1 ' CD4' and CD8' TCR subsets occurred (Fig 2, P < .
OS). Donor chimerism correlates with deletion of donor-reacrive TCR-V, subsets.
To determine whether the presence of donor BM-derived cells must be maintained for deletion of potentially donor-reactive T-cell subsets to occur, the TCR-V, repertoire was examined in a subgroup of chimeras conditioned with SO0 cGy TB1 without CyP after donor BM transplantation. Conditioning with TB1 alone was insufficient for durable donor engraftment, resulting in syngeneic (BIO) reconstitution in all recipients, as assessed I month after transplantation by PBL typing (n = S). The deletion of donor-reactive V,-TCR subsets directly correlated with the presence of donor chimerism ( Table   2 , P < .OOOl). All recipients conditioned with TB1 and CyP showed evidence of donor chimerism (61.9% 2 7.3%; n = IS) and deleted V$" and Vbl 1' T-cell subsets. In contrast, normal B10 mice and recipients without evidence of donor chimerism (TB1 alone) did not delete V$' and V,I I' T cells from the peripheral TCR repertoire. l', and V, 14' in host (B10; n = 4). donor (BALBlc; n = 31, and partially ablated chimeras (BALBlrB10; n = 6). V,-TCR expression in chimeras was compared with B10 mice, with significant P values indicated above the respective data bars ('P S .05 and t P S .0005). Comparison of V, -TCR expression between BALBlc and chimeras was not statistically significant for any given V, , by Student's t test analysis.
Specijc V, deletion occurs in both host-and donor-derived lineages. Due to the high level of donor chimerism present in partially ablated recipient chimeras, it was possible that donor-reactive V,-TCR+ cells were deleted from the 
Normal B10 2.7 f 0.6 9.4 f 1. Relative VA5 and V n l l expression (mean 2 SEM) of CD4' and CD8' splenicT-cell subsets in normal B10 mice (host strain; n = 16). conditioned (BALB/c -B10 and B1O.BR -610) chimeras, (TB1 + CyP; n = 15) or recipients that failed to engraft (TB1 alone; n = 5). Donor chimerism was determined by PBL typing 1 month following reconstitution.
Comparison of relative V. expression: chimerism versus no chimerism by Student's t test, P < ,0001 for all V,-TCR' subsets. donor TCR repertoire, but that the host-derived TCR repertoire remained permissive for expression of these subfamilies. Therefore, splenocytes from partially ablated B IO.BR+BIO and BALB/rBIO chimeras, previously shown to delete V$+ TCR subsets, were analyzed for coexpression of host (H-2") class I' antigen and V$' or V86+ TCR. Donor-reactive V,$' T cells were deleted from the host-derived TCR repertoire ( P = .003), whereas the level of expression of V,6" TCR analyzed as a control was unaffected ( Table 3) .
Host-derived deletion ligands are present in partially ablated recipients. Previous studies using lethal recipient conditioning have shown that the pattern of V, deletion is mediated, for the most part, by the deletion ligands of the BM donor, rather than those expressed by the recipient of the marrow. Therefore, it is not surprising that potentially host-reactive V,T cells are not efficiently deleted when the donor is permissive for VD expression, as in (I-E-+I-E&) chimerasA6 It has been previously shown that chimeras reconstituted with a mixture of host and donor hematopoietic stem cells are relatively resistant to GVHD as compared with lethally irradiated fully allogeneic chimera^.^'^*" There- and V014+ TCR subsets approximated that present in the host with the efficient deletion of V$ and V,I
1 TCR subsets (Fig 3; P < .002). In striking contrast, V$' T cells were not deleted and V,1 1 + T cells were only decreased ( P < .Ol), but not ablated, in BIO.BR recipients conditioned with complete ablation. of nonmyeloablated recipients.
Negative selection of V,+ T cells occurs within the thymus
The interaction of pre-T cells with stroma and BM-derived elements in the thymus results in the development of phenotypically and functionally mature T cells. Phenotypically immature (CD4TD8-), intermediate (CD4'CD8+), and mature (CD4'CD8-or CD4-CD8') thymocyte subsets of donor and recipient origin were present within the thymus of partially ablated chimeras (n = 3) after reconstitution, suggesting that repopulation of the thymus occurs in the partially myeloablated host ( Table  4) .
Negative selection of V4 T-cell subsets has been shown to occur in fully ablated recipients before development of the mature single positive phenotype.h To confirm that V, deletion in a partially myeloablated host was due to intrathymic negative selection, expression of V03, V$, VB6, and
Vpll on double-positive (CD4TD8') and mature, singlepositive (CD4'CD8-or CD4-CD8') thymocytes was examined in BALB/c-+BlO nonlethal chimeras. As in the peripheral TCR repertoire, V03', V$', and Vpl I + bright thymocytes were absent in the mature CD4'CDX" and CD4-CD8' thymocyte subsets in partially ablated chimeras ( P < .05), but Vp6' expression, analyzed as a control, was not affected ( Table 5) . In contrast, dim Vp3', V$' . Vpl I + expression found on double-positive thymocytes was comparable between chimeras and controls. suggesting that negative selection of V, subsets in partially ablated recipients occurs within the thymus, before the development of the mature single-positive thymocyte populations.
Host-derived I-E' cells are present within the thymus of partially ablated recipients. The deletion of potentially autoreactive T cells in completely ablated chimeras is associated with expression of the I-E molecule on BM-derived dendritic cells within the medulla of the host thymus.""-s" We hypothesized that efficient deletion of host-reactive V,-TCR subsets in partially ablated B IWBIO.BR chimeras, but not after complete myeloablation, may be due to the presence of host I-E' cells within the thymus. Thymi from completely and partially ablated chimeras were histologically analyzed for the presence of host I-E' cells. Intense staining for I-E' antigen was present within the medullary regions of thymi obtained from BIWB1O.BR partially ablated chimeras, and resembled the immunohistology seen in unmanipulated BIO.BR controls (Fig 4) . In contrast, LEk expression was markedly decreased in the thymi of completely ablated chimeras, being present in small areas scattered primarily throughout the thymic cortex. Taken together, these results suggest that the BM-derived cells of the host thymus, which are necessary for deletion of potentially host-reactive T-cell populations, are present and functional in chimeras conditioned with partial myeloablation.
DISCUSSION
Negative selection of potentially autoreactive V,+ T cells has been observed to occur at the CD4TD8' stage of intrathymic development.".'".'' The relative contribution of radioresistant epithelial and radiosensitive hematopoietic elements (macrophages and dendritic cells) to clonal deletion have been separated using radiation BM In fully ablated recipients reconstituted with allogeneic BM (A-+B), the thymic epithelium is of host origin and the hematopoietic elements originate from the donor BM inocula. The pattern of V, deletion has been shown to be almost exclusively mediated by donor-derived BM cells, and not the host epithelium, in the thymus of these recipients.'' In CD8' ), or mature (CD4'CDS-or CD4'CD8') thymocytes were analyzed by flow cytometry in control host (B10; n = 3), donor (BALWc; n = 2), or partially ablated BALB/c -t E10 chimeras (n = 3). A number of models have achieved chimerism and tolerance without complete recipient ablation. However, the mechanism for the induction and maintenance of tolerance in these models has not been clearly defined. Congeneic recipients tolerized with donor splenocytes (DBA/2+BALB/ c) plus a single dose of CyP 2 days later initially showed the intrathymic deletion of donor-reactive V,6' cells and elimination of donor-antigen stimulated CD4' T cells in the periphery.'2 However, VB6+ CD4' T cells reemerged 70 to 100 days later. Despite the loss of intrathymic mixed chimerism and V06 deletion, tolerance was maintained rhrough the development of antigen-specific suppressor T cells. Similarly, CyP-induced tolerance after the transplantation of splenocytes and BM from H-2D and I-E loci-disparate donors (BIO.A[5R]+B10) was associated with donor chimerism and the deletion of donor-reactive V,I I' T cells only for the first month.'' Tolerance was maintained in the recipient through clonal anergy, demonstrating that long-term tolerance to minor or partial MHC disparities does not require clonal deletion. In contrast, when fully MHC-disparate B 10 (H-2') recipients were pretreated with anti-CD4 and CD8 MoAbs in vivo in conjunction with 300 cGy TBI and 700 cGy thymic irradiation before transplantation with untreated B 10.A (H-2") donor BM, complete deletion of autoreactive Vg 1 1 ' T cells did not occur until 3 months after transplantation." Instead, residual VO1l+ T cells were initially anergic and eventually disappeared in association with the intrathymic deletion of mature Vpl 1 + thymocytes. Clearly, the permanence of clonal deletion varies among the nonablative models, and is influenced by the conditioning regimen used, the degree of MHC disparity between donor and host, and the presence of donor chimerism. The results of these studies suggest that the importance of clonal deletion and permanent donor chimerism increases with increasing antigenic disparity between the donor and recipient.
The current study has investigated the mechanism of induction and maintenance of tolerance after a radiation-based nonmyeloablative conditioning approach to achieve mixed allogeneic chimerism in highly disparate donor and recipient combinations. Transplantation of donor BM after conditioning with 500 cGy of TBI fails to result in donor chimerism and tolerance unless a single dose of CyP is administered on day +2. 28 Recipients of TBI plus CyP conditioning exhibit multilineage mixed chimerism, in vitro tolerance for both host and donor alloantigens, and the long-term acceptance of donor skin and primarily vascularized cardiac allografts. This conditioning approach is not completely ablative, because recipients that are conditioned, but not transplanted, survive and repopulate as syngeneic. The current study demonstrates that the induction of donor chimerism across multiple MHC, minor, and Hh-I histocompatibility disparities in partially ablated recipients is also associated with the dele- tion of potentially donor-and host-reactive V$ T cells. Recipients without evidence of donor chimerism, shown previously not to exhibit donor-specific tolerance, also do not delete donor-reactive V$ subsets. Therefore, clonal deletion may be a critical requirement for the induction of tolerance in partially ablated recipients, with the prominent role of clonal anergy in tolerance induction being unique to MoAbinduced tolerance models. The mechanism(s) required for the induction and maintenance of tolerance may be important for the clinical application of chimerism, because T-cell unresponsiveness due to anergy, unlike deletional tolerance, can be bypassed by the exogenous or endogenous presence of T-cell-activating cytokines during periods of immune activation.lx."." One could hypothesize that the most robust, and therefore preferred, approach for achieving donor-specific transplantation tolerance would be deletional, if it could be achieved without significant morbidity.
In the current model of partial recipient ablation, donor chimerism across MHC and minor histocompatibility disparities is achieved in the context of clonal deletion and maintained for up to 17 months posttransplant. The deletion of V$' and V,I 1' peripheral T cells occurred in partially ablated B IO.BR+B I O chimeras. Furthermore, V,-TCR subsets were analyzed in BALB/c+BlO nonlethal chimeras, which are disparate for MHC, MIS, and Hh-l antigens. The TCR repertoire of these chimeras delete V,3+, V$' , and V,I 1' TCR subsets as dictated by the BALBk integrant products. Therefore, donor-derived elements can contribute the ligand for deletion, regardless of the degree of donor and recipient disparity and whether the recipient is conditioned with complete or partial myeloablation. Intrathymic clonal deletion requires that a permanent source of deletion ligand be present within the thymus, and therefore, V, deletion does not occur in this model, or in others, without the presence of donor chimerism.3' Thus, the permanent engraftment of donor hematopoietic stem cells across MHC, minor, and Hh-l antigenic barriers with this nonlethal approach is central to the ability to maintain long-term clonal deletion and donor-specific tolerance.
Partially conditioned B IWB IO.BR chimeras deleted hostreactive V,S+ and V,I lished that these T cells are tolerized in the lethally conditioned recipient via a mechanism of clonal Unlike clonal deletion, tolerance in these models can be overcome in vitro in the presence of exogenous IL-2. In the lethally ablated recipient, it was unclear whether deletion did not occur because the I-E-donor was unable to delete hostreactive V i thymocytes or whether the I-E+ thymus was no longer able to support negative selection. The deletion of host-reactive V$ subfamilies in partially ablated recipients suggests that developing donor lymphocytes can undergo negative selection in an I-E+ thymic environment, if the appropriate cellular components are present. This hypothesis is supported by the presence of host I-Ek+ cells in the thymus of B 1 W B 10.BR chimeras after partial recipient ablation. In contrast, expression of I-Ek within the thymic medulla is no longer present in B 10.BR recipients after completely ablative conditioning, and thus B 1 W B 10.BR fully ablated chimeras do not delete host-reactive V,+ T cells. The immunohistologic presence of I-Ek+ cells after the current nonlethal conditioning approach confirms the nonablative nature of the host conditioning and suggests that BM-derived I-E+ cells, of either donor or host origin, may contribute the ligands for clonal deletion. Therefore, as in fully allogeneic chimeras, BM-derived elements contribute to the deletion ligands required for negative selection. The advantage in mixed chimeras, whether prepared with complete or partial host ablation, is that both donor and host-derived BM elements are present to result in clonal deletion instead of anergic tolerance.
Thymic selection is influenced by (1) the avidity of the interaction between the thymocyte TCR and the MHC/deleting ligand complex of the BM-derived thymic stroma, (2) the affinity of the thymocyte TCR for the stromal complex, and (3) the likelihood that maturing thymocytes encounter the deleting ligand.s4-56 The level of donor chimerism and the conditioning of the host should not affect the avidity or intrinsic affinity of thymocytes for the deleting ligands. However, the deletion of V$+ and V,11+ subfamilies in partially ablated recipients with donor chimerism ranging from 12% to 70% suggests that the number of MHC-bearing stromal cells, although important for negative selection, does not solely determine the likelihood of thymocyte-ligand interaction. Negative selection is thought to occur within the thymic medulla, most efficiently at the corticomedullary junction, where BM-derived I-E+ cells are normally concentrated."6,s7 However, the thymic distribution of I-E+ cells can be significantly different depending on the degree and approach of host conditioning. After partial myeloablative conditioning, I-E+ cells were present in a relatively normal pattern of intramedullary distribution. In contrast, complete myeloablation altered this distribution resulting in the presence of islands of I-E+ cells throughout the thymus. These findings suggest that the incomplete negative selection of host-reactive V, subfamilies seen in fully ablated recipients may result from the disruption of the medullary architecture necessary for efficient V, deletion to occur, rather than simply fewer LE+ stromal cells.
Mixed chimeras are more resistant to GVHD than are fully allogeneic chimeras." Consistent with the presence of potentially host-reactive V,-TCR subsets of donor origin in B l W B 10.BR fully allogeneic chimeras, chimeras prepared by complete ablation and transplanted with untreated allogeneic BM cells have been shown to exhibit GVHD in vivo.24,58,59 In striking contrast, lymphocytes from partially ablated mixed allogeneic chimeras do not exhibit anti-host or anti-donor reactivity in vitro or in vivo. 28 We have shown that this state of reciprocal cotolerance is associated with the deletion of autoreactive V, subfamilies from both host and donor TCR repertoires, as evidenced by the absence of the V$+ subfamily in BALB/c+BlO chimeras, even among the small percentage of host-derived (H-2b+) lymphocytes. The unique ability of mixed chimeras to induce clonal deletion of potentially host-as well as donor-reactive V; populations, suggests that this reciprocal cotolerance may result from donor and host hematopoietic populations each contributing the ligands required for efficient deletion of autoreactive T cells. One could hypothesize that activated donor-or host-reactive T cells would reenter the thymus, encounter their deleting ligand, and be removed from the T-cell reper-
The present model differs from other approaches for partial conditioning in that CyP is administered 2 days after transplantation of the donor BM inoculum, theoretically providing an antiproliferative agent during the time of maximum donor antihost (and host antidonor) rea~tivity.~'.~' Therefore, we hypothesize that the primary mechanism for inducing and maintaining tolerance in the TBVCyP model is deletional, but involves at least three contributing factors: ( l ) cytoreduction for donor stem-cell engraftment so that a permanent source of donor antigen is present; ( 2 ) CyP on day +2 contributes to the elimination of proliferating mature donor antihost T cells contaminating the marrow inoculum and host antidonor T cells remaining after partial host myeloablation; and (3) the multilineage chimerism resulting from the coengraftment of donor and host hematopoietic stem cells includes I-E' stromal (dendritic) cells, which efficiently present deleting ligands within the medulla of the thymus, therefore providing the optimal environment for deletional rather than anergic tolerance of developing T cells.
Analysis of V, expression in different strain combinations of nonlethal chimeras (BIO.BR-tBl0; BlWB1O.BR; and BALB/c-+BlO) has allowed us to evaluate the importance of Mls and I-E antigen expression by host and donor elements, on the induction and maintenance of tolerance in partially ablated host environment. We have found that the presence of stable donor chimerism is associated with the deletion of autoreactive T-cell subfamilies and that both host and donor BM-derived cells in partially ablated chimeras can contribute to the intrathymic clonal elimination of potentially host-, as well as donor-reactive T-cell populations. Clonal deletion of both host-and donor-reactive T cells across MHC and minor antigen barriers may, in fact, decrease the risk of GVHD and allograft rejection. As we better understand the mechanism(s) for tolerance induction and maintenance in partially ablated recipients, new strategies will emerge in which deletional tolerance is favored over anergy as a means to induce durable donor-specific tolerance with minimal recipient morbidity and mortality in the clinical setting.
For
